We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$4B
AUM Growth
-$1.25B
Cap. Flow
-$1.28B
Cap. Flow %
-32.02%
Top 10 Hldgs %
20.82%
Holding
1,612
New
626
Increased
195
Reduced
208
Closed
487

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$10.2M
2
PARA
Paramount Global Class B
PARA
+$6.08M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.95M
4
BIIB icon
Biogen
BIIB
+$5.94M
5
AON icon
Aon
AON
+$5.61M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$294M
2
LEN icon
Lennar Class A
LEN
+$76.3M
3
RH icon
RH
RH
+$25.1M
4
ARKG icon
ARK Genomic Revolution ETF
ARKG
+$22.5M
5
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$22.5M

Sector Composition

Rank Sector Weight
1 Healthcare 1.79%
2 Communication Services 1.57%
3 Technology 1.13%
4 Consumer Discretionary 1.05%
5 Financials 0.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZN icon
926
AstraZeneca
AZN
$269B
$249K 0.01%
+2,500
New +$251K
CAN
927
Canaan Creative
CAN
$172M
$248K 0.01%
+12,000
New +$179K
ADMA icon
928
PUT
ADMA Biologics
ADMA
$2.02B
$245K 0.01%
+139,000
New +$318K
LAZR
929
DELISTED
Luminar Technologies
LAZR
$243K 0.01%
+667
New +$302K
VIHAU
930
DELISTED
VPC Impact Acquisition Holdings Unit
VIHAU
$243K 0.01%
17,000
-13,000
-43% -$219K
VERI icon
931
CALL
Veritone
VERI
$92.9M
$240K 0.01%
+10,000
New +$357K
CVET
932
DELISTED
Covetrus, Inc. Common Stock
CVET
$238K 0.01%
+7,930
New +$270K
TWO
933
Two Harbors Investment
TWO
$1.27B
$237K 0.01%
+8,100
New +$222K
GBX icon
934
PUT
The Greenbrier Companies
GBX
$1.57B
$236K 0.01%
+5,000
New +$214K
LSAK icon
935
Lesaka Technologies
LSAK
$384M
$235K 0.01%
+42,017
New +$219K
PAGP icon
936
PUT
Plains GP Holdings
PAGP
$5.28B
$235K 0.01%
+25,000
New +$233K
CAG icon
937
CALL
Conagra Brands
CAG
$7.42B
$233K 0.01%
6,200
-35,100
-85% -$1.24M
ALXN
938
DELISTED
Alexion Pharmaceuticals
ALXN
$229K 0.01%
1,500
-28,800
-95% -$4.45M
SLV icon
939
CALL
iShares Silver Trust
SLV
$27.7B
$227K 0.01%
+10,000
New +$243K
REAL icon
940
PUT
The RealReal
REAL
$1.41B
$226K 0.01%
+10,000
New +$246K
XERS icon
941
CALL
Xeris Biopharma Holdings
XERS
$1.45B
$226K 0.01%
50,000
– –
OPLN
942
Openlane
OPLN
$4.28B
$225K 0.01%
+15,000
New +$255K
ASPN icon
943
CALL
Aspen Aerogels
ASPN
$339M
$222K 0.01%
+10,900
New +$230K
CABA icon
944
CALL
Cabaletta Bio
CABA
$427M
$222K 0.01%
+20,000
New +$244K
CNX icon
945
CALL
CNX Resources
CNX
$4.91B
$221K 0.01%
15,000
– –
MTVA
946
CALL
MetaVia Inc
MTVA
$7.44M
$220K 0.01%
+19
New +$256K
MPLX icon
947
CALL
MPLX
MPLX
$58.6B
$218K 0.01%
+8,500
New +$209K
YEXT icon
948
CALL
Yext
YEXT
$573M
$217K 0.01%
+15,000
New +$250K
ANAB icon
949
AnaptysBio
ANAB
$1.54B
$216K 0.01%
+10,000
New +$252K
RIGL icon
950
Rigel Pharmaceuticals
RIGL
$723M
$216K 0.01%
6,330
+580
+10% +$23K
36 37
38
39 40

Similar funds

EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
MAM
Moelis Asset Management New York $5.32M AUM
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

SG3 Management's Q1 2021 Portfolio in Review

As of Q1 2021, SG3 Management held 1,612 positions worth $4B, down 24% from $5.25B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

SG3 Management withdrew a net $1.28B in Q1 2021, closing 487 positions and reducing 208 holdings. Its most notable exit was Amazon, an estimated $294M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 0.67% a quarter earlier, followed by Communication Services and Technology.

Against the trend, SG3 Management opened a new position in Albemarle worth $4.16M.

  • SG3 Management's largest Q1 2021 buy was Albemarle: 28,500 shares worth $4.16M.
  • SG3 Management added most to Jazz Pharmaceuticals in Q1 2021, an estimated $10.2M increase.
  • SG3 Management's biggest Q1 2021 reduction was RH, cutting an estimated $25.1M.
  • SG3 Management fully exited Amazon in Q1 2021, selling an estimated $294M.
  • SG3 Management's ten largest holdings make up 21% of its $4B portfolio in Q1 2021.
  • SG3 Management opened 626 new positions and closed 487 in Q1 2021.
  • SG3 Management's portfolio value fell 24% quarter-over-quarter to $4B.

Based on SG3 Management's 13F filing for Q1 2021, filed 17 May 2021.